ASPG and acute lymphoblastic leukemia: Glucocorticoids, such as prednisolone, asparaginase, or vincristine, are regularly used for the treatment of ALL, and resistance to glucocorticoids has been defined as an important adverse prognostic factor in newly diagnosed ALL patients.